Omidria approved for pediatric patients
- Posted on: Dec 12 2017
The FDA has expanded the indication for Omidria, a mydriatic and NSAID combination agent, to include use in pediatric patients from birth through 17 years.
Source: AAO
Posted in: Practice News
